Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+109.8%
5Y CAGR+84.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+109.8%/yr
vs +54.5%/yr prior
5Y CAGR
+84.7%/yr
Recent acceleration
Acceleration
+55.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
21.5x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $350.79M | +663.5% |
| 2024 | $45.94M | +7.1% |
| 2023 | $42.90M | +12.9% |
| 2022 | $38.00M | +21.8% |
| 2021 | $31.20M | +91.3% |
| 2020 | $16.31M | +95.9% |
| 2019 | $8.33M | +24.8% |
| 2018 | $6.67M | - |